Global Oncology Based In-vitro CRO Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Oncology Based In-vitro CRO Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Oncology Based In-vitro CRO Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Blood Cancer
  • 1.4.3 Solid Tumors
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Oncology Based In-vitro CRO Market Share by Application: 2020 VS 2026
  • 1.5.2 Pharmaceutical & Biopharmaceutical Industries
  • 1.5.3 Medical Device Companies
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Oncology Based In-vitro CRO Market Perspective (2015-2026)
• 2.2 Oncology Based In-vitro CRO Growth Trends by Regions
  • 2.2.1 Oncology Based In-vitro CRO Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Oncology Based In-vitro CRO Historic Market Share by Regions (2015-2020)
  • 2.2.3 Oncology Based In-vitro CRO Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Oncology Based In-vitro CRO Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Oncology Based In-vitro CRO Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology Based In-vitro CRO Players by Market Size
  • 3.1.1 Global Top Oncology Based In-vitro CRO Players by Revenue (2015-2020)
  • 3.1.2 Global Oncology Based In-vitro CRO Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Oncology Based In-vitro CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Oncology Based In-vitro CRO Market Concentration Ratio
  • 3.2.1 Global Oncology Based In-vitro CRO Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Oncology Based In-vitro CRO Revenue in 2019
• 3.3 Oncology Based In-vitro CRO Key Players Head office and Area Served
• 3.4 Key Players Oncology Based In-vitro CRO Product Solution and Service
• 3.5 Date of Enter into Oncology Based In-vitro CRO Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Oncology Based In-vitro CRO Historic Market Size by Type (2015-2020)
• 4.2 Global Oncology Based In-vitro CRO Forecasted Market Size by Type (2021-2026)

5 Oncology Based In-vitro CRO Breakdown Data by Application (2015-2026)

• 5.1 Global Oncology Based In-vitro CRO Market Size by Application (2015-2020)
• 5.2 Global Oncology Based In-vitro CRO Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Oncology Based In-vitro CRO Market Size (2015-2020)
• 6.2 Oncology Based In-vitro CRO Key Players in North America (2019-2020)
• 6.3 North America Oncology Based In-vitro CRO Market Size by Type (2015-2020)
• 6.4 North America Oncology Based In-vitro CRO Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Oncology Based In-vitro CRO Market Size (2015-2020)
• 7.2 Oncology Based In-vitro CRO Key Players in Europe (2019-2020)
• 7.3 Europe Oncology Based In-vitro CRO Market Size by Type (2015-2020)
• 7.4 Europe Oncology Based In-vitro CRO Market Size by Application (2015-2020)

8 China

• 8.1 China Oncology Based In-vitro CRO Market Size (2015-2020)
• 8.2 Oncology Based In-vitro CRO Key Players in China (2019-2020)
• 8.3 China Oncology Based In-vitro CRO Market Size by Type (2015-2020)
• 8.4 China Oncology Based In-vitro CRO Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Oncology Based In-vitro CRO Market Size (2015-2020)
• 9.2 Oncology Based In-vitro CRO Key Players in Japan (2019-2020)
• 9.3 Japan Oncology Based In-vitro CRO Market Size by Type (2015-2020)
• 9.4 Japan Oncology Based In-vitro CRO Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Oncology Based In-vitro CRO Market Size (2015-2020)
• 10.2 Oncology Based In-vitro CRO Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Oncology Based In-vitro CRO Market Size by Type (2015-2020)
• 10.4 Southeast Asia Oncology Based In-vitro CRO Market Size by Application (2015-2020)

11 India

• 11.1 India Oncology Based In-vitro CRO Market Size (2015-2020)
• 11.2 Oncology Based In-vitro CRO Key Players in India (2019-2020)
• 11.3 India Oncology Based In-vitro CRO Market Size by Type (2015-2020)
• 11.4 India Oncology Based In-vitro CRO Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Oncology Based In-vitro CRO Market Size (2015-2020)
• 12.2 Oncology Based In-vitro CRO Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Oncology Based In-vitro CRO Market Size by Type (2015-2020)
• 12.4 Central & South America Oncology Based In-vitro CRO Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Crown Bioscience
  • 13.1.1 Crown Bioscience Company Details
  • 13.1.2 Crown Bioscience Business Overview and Its Total Revenue
  • 13.1.3 Crown Bioscience Oncology Based In-vitro CRO Introduction
  • 13.1.4 Crown Bioscience Revenue in Oncology Based In-vitro CRO Business (2015-2020))
  • 13.1.5 Crown Bioscience Recent Development
• 13.2 Charles River Laboratory
  • 13.2.1 Charles River Laboratory Company Details
  • 13.2.2 Charles River Laboratory Business Overview and Its Total Revenue
  • 13.2.3 Charles River Laboratory Oncology Based In-vitro CRO Introduction
  • 13.2.4 Charles River Laboratory Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.2.5 Charles River Laboratory Recent Development
• 13.3 ICON Plc.
  • 13.3.1 ICON Plc. Company Details
  • 13.3.2 ICON Plc. Business Overview and Its Total Revenue
  • 13.3.3 ICON Plc. Oncology Based In-vitro CRO Introduction
  • 13.3.4 ICON Plc. Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.3.5 ICON Plc. Recent Development
• 13.4 Eurofins Scientific
  • 13.4.1 Eurofins Scientific Company Details
  • 13.4.2 Eurofins Scientific Business Overview and Its Total Revenue
  • 13.4.3 Eurofins Scientific Oncology Based In-vitro CRO Introduction
  • 13.4.4 Eurofins Scientific Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.4.5 Eurofins Scientific Recent Development
• 13.5 Taconic Biosciences
  • 13.5.1 Taconic Biosciences Company Details
  • 13.5.2 Taconic Biosciences Business Overview and Its Total Revenue
  • 13.5.3 Taconic Biosciences Oncology Based In-vitro CRO Introduction
  • 13.5.4 Taconic Biosciences Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.5.5 Taconic Biosciences Recent Development
• 13.6 Covance
  • 13.6.1 Covance Company Details
  • 13.6.2 Covance Business Overview and Its Total Revenue
  • 13.6.3 Covance Oncology Based In-vitro CRO Introduction
  • 13.6.4 Covance Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.6.5 Covance Recent Development
• 13.7 EVOTEC
  • 13.7.1 EVOTEC Company Details
  • 13.7.2 EVOTEC Business Overview and Its Total Revenue
  • 13.7.3 EVOTEC Oncology Based In-vitro CRO Introduction
  • 13.7.4 EVOTEC Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.7.5 EVOTEC Recent Development
• 13.8 The Jackson Laboratory
  • 13.8.1 The Jackson Laboratory Company Details
  • 13.8.2 The Jackson Laboratory Business Overview and Its Total Revenue
  • 13.8.3 The Jackson Laboratory Oncology Based In-vitro CRO Introduction
  • 13.8.4 The Jackson Laboratory Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.8.5 The Jackson Laboratory Recent Development
• 13.9 Wuxi AppTec.
  • 13.9.1 Wuxi AppTec. Company Details
  • 13.9.2 Wuxi AppTec. Business Overview and Its Total Revenue
  • 13.9.3 Wuxi AppTec. Oncology Based In-vitro CRO Introduction
  • 13.9.4 Wuxi AppTec. Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.9.5 Wuxi AppTec. Recent Development
• 13.10 MI Bioresearch, Inc.
  • 13.10.1 MI Bioresearch, Inc. Company Details
  • 13.10.2 MI Bioresearch, Inc. Business Overview and Its Total Revenue
  • 13.10.3 MI Bioresearch, Inc. Oncology Based In-vitro CRO Introduction
  • 13.10.4 MI Bioresearch, Inc. Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 13.10.5 MI Bioresearch, Inc. Recent Development
• 13.11 Champion Oncology, Inc.
  • 10.11.1 Champion Oncology, Inc. Company Details
  • 10.11.2 Champion Oncology, Inc. Business Overview and Its Total Revenue
  • 10.11.3 Champion Oncology, Inc. Oncology Based In-vitro CRO Introduction
  • 10.11.4 Champion Oncology, Inc. Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 10.11.5 Champion Oncology, Inc. Recent Development
• 13.12 Xentech
  • 10.12.1 Xentech Company Details
  • 10.12.2 Xentech Business Overview and Its Total Revenue
  • 10.12.3 Xentech Oncology Based In-vitro CRO Introduction
  • 10.12.4 Xentech Revenue in Oncology Based In-vitro CRO Business (2015-2020)
  • 10.12.5 Xentech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer